Camlin Fine Sciences Limited
Camlin Fine Sciences is engaged in the Business of Speciality Chemicals.
What Camlin files
- Others88
- Investor Meet28
- Important23
- Updates14
- Board Meeting11
- PPTs8
Camlin Fine Sciences has announced its 33rd Annual General Meeting (AGM). The FY2025-26 Annual Report is available online. Shareholders should update KYC details and dematerialize physical shares for smooth payments.
Camlin Fine Sciences successfully completed its cash tender offer for Vinpai shares. CFSL now holds 95.41% of Vinpai's share capital and 91.46% of voting rights, boosting its presence in shelf life and health & wellness ingredients. No squeeze-out planned.
Camlin Fine Sciences (CFSL) received French clearance for its mandatory tender offer for remaining Vinpai shares at EUR 3.60 each. CFSL already holds 83.82% of Vinpai, aiming to secure full ownership of the shelf-life solutions firm.
Camlin Fine Sciences filed an offer to buy remaining Vinpai shares at EUR 3.60 each, matching its prior stake purchase. CFSL now owns 83.82% of Vinpai. Vinpai's Board finds the offer fair for minority holders. CFSL will not delist Vinpai.
Camlin Fine Sciences (CFSL) postponed its Vinpai tender offer filing to early May. The Euro 3.60 per share offer price remains. CFSL will not pursue a squeeze-out, keeping Vinpai listed to support European synergies and financing.